CTXR

Citius Pharmaceuticals (CTXR)

About Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Details

Daily high
$0.43
Daily low
$0.39
Price at open
$0.42
52 Week High
$1.07
52 Week Low
$0.39
Market cap
71.4M
Dividend yield
0.00%
Volume
17,994
Avg. volume
1.0M
P/E ratio
-1.62

Citius Pharmaceuticals News

Details

Daily high
$0.43
Daily low
$0.39
Price at open
$0.42
52 Week High
$1.07
52 Week Low
$0.39
Market cap
71.4M
Dividend yield
0.00%
Volume
17,994
Avg. volume
1.0M
P/E ratio
-1.62